{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T04:40:01Z","timestamp":1742013601593,"version":"3.38.0"},"reference-count":33,"publisher":"Tohoku University Medical Press","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2025]]},"DOI":"10.1620\/tjem.2024.j082","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T22:12:54Z","timestamp":1725487974000},"page":"99-111","source":"Crossref","is-referenced-by-count":0,"title":["The Molecular Mechanism by which LINC00461 Regulates Carfilzomib Resistance in Multiple Myeloma"],"prefix":"10.1620","volume":"265","author":[{"given":"Lifang","family":"Cheng","sequence":"first","affiliation":[{"name":"Department of Haematology, Shenshan Medical Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanjuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Emergency, Shenzhen Samii Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Abdi, J., Chen, G. &amp; Chang, H.(2013)  Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms.  <i>Oncotarget<\/i>, 4, 2186-2207.","DOI":"10.18632\/oncotarget.1497"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Acosta-Alvear, D., Cho, M.Y., Wild, T., Buchholz, T.J., Lerner, A.G., Simakova, O., Hahn, J., Korde, N., Landgren, O., Maric, I., Choudhary, C., Walter, P., Weissman, J.S. &amp; Kampmann, M.(2015)  Paradoxical resistance of multiple myeloma to proteasome inhibitors by decreased levels of 19S proteasomal subunits.  <i>Elife<\/i>, 4, e08153.","DOI":"10.7554\/eLife.08153"},{"key":"3","unstructured":"Anderson, K.C.(2004)  Bortezomib therapy for myeloma.  <i>Curr. Hematol. Rep<\/i>., 3, 65."},{"key":"4","doi-asserted-by":"crossref","unstructured":"Besse, A., Stolze, S.C., Rasche, L., Weinhold, N., Morgan, G.J., Kraus, M., Bader, J., Overkleeft, H.S., Besse, L. &amp; Driessen, C.(2018)  Carfilzomib resistance due to ABCB1\/MDR1 overexpression is overcome by nelfinavir and lopinavir in multiple myeloma.  <i>Leukemia<\/i>, 32, 391-401.","DOI":"10.1038\/leu.2017.212"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Chen, Y., He, J., Su, C., Wang, H., Chen, Y., Guo, W., Li, Y. &amp; Ding, G.(2019)  LINC00461 affects the survival of patients with renal cell carcinoma by acting as a competing endogenous RNA for microRNA-942.  <i>Oncol. Rep<\/i>., 42, 1924-1934.","DOI":"10.3892\/or.2019.7311"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Deng, M., Yuan, H., Liu, S., Hu, Z. &amp; Xiao, H.(2019)  Exosome-transmitted LINC00461 promotes multiple myeloma cell proliferation and suppresses apoptosis by modulating microRNA\/BCL-2 expression.  <i>Cytotherapy<\/i>, 21, 96-106.","DOI":"10.1016\/j.jcyt.2018.10.006"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Deng, M., Yuan, H., Peng, H., Liu, S., Xiao, X., Wang, Z., Zhang, G. &amp; Xiao, H.(2023)  LINC00461 Knockdown Enhances the Effect of Ixazomib in Multiple Myeloma Cells.  <i>Curr. Cancer Drug Targets<\/i>, 23, 643-652.","DOI":"10.2174\/1568009623666230316152713"},{"key":"8","unstructured":"Gong, Y.B. &amp; Fan, X.H.(2019)  MiR-539-3p promotes the progression of epithelial ovarian cancer by targeting SPARCL1.  <i>Eur. Rev. Med. Pharmacol. Sci<\/i>., 23, 2366-2373."},{"key":"9","doi-asserted-by":"crossref","unstructured":"Gorji-Bahri, G., Moghimi, H.R. &amp; Hashemi, A.(2021)  RAB5A effect on metastasis of hepatocellular carcinoma cell line via altering the pro-invasive content of exosomes.  <i>Exp. Mol. Pathol<\/i>., 120, 104632.","DOI":"10.1016\/j.yexmp.2021.104632"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Hou, J., Wang, Y., Zhang, H., Hu, Y., Xin, X. &amp; Li, X.(2020)  Silencing of LINC00461 enhances radiosensitivity of lung adenocarcinoma cells by down-regulating HOXA10 via microRNA-195.  <i>J. Cell Mol. Med<\/i>., 24, 2879-2890.","DOI":"10.1111\/jcmm.14859"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Huarte, M.(2015)  The emerging role of lncRNAs in cancer.  <i>Nat. Med<\/i>., 21, 1253-1261.","DOI":"10.1038\/nm.3981"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Kamerkar, S., LeBleu, V.S., Sugimoto, H., Yang, S., Ruivo, C.F., Melo, S.A., Lee, J.J. &amp; Kalluri, R.(2017)  Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer.  <i>Nature<\/i>, 546, 498-503.","DOI":"10.1038\/nature22341"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Li, Y., Chen, Z.K., Duan, X., Zhang, H.J., Xiao, B.L., Wang, K.M. &amp; Chen, G.(2022)  Targeted inhibition of tumor-derived exosomes as a novel therapeutic option for cancer.  <i>Exp. Mol. Med<\/i>., 54, 1379-1389.","DOI":"10.1038\/s12276-022-00856-3"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Li, Y., Sun, X., Ji, D., Kong, X., Liu, D., Zhao, Z., Yan, J. &amp; Chen, S.(2017)  Expression of Rab5a correlates with tumor progression in pancreatic carcinoma.  <i>Virchows Arch<\/i>., 470, 527-536.","DOI":"10.1007\/s00428-017-2098-y"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Lischnig, A., Bergqvist, M., Ochiya, T. &amp; Lasser, C.(2022)  Quantitative Proteomics Identifies Proteins Enriched in Large and Small Extracellular Vesicles.  <i>Mol. Cell Proteomics<\/i>, 21, 100273.","DOI":"10.1016\/j.mcpro.2022.100273"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Ma, W., Zhao, F., Yu, X., Guan, S., Suo, H., Tao, Z., Qiu, Y., Wu, Y., Cao, Y. &amp; Jin, F.(2020)  Immune-related lncRNAs as predictors of survival in breast cancer: a prognostic signature.  <i>J. Transl. Med<\/i>., 18, 442.","DOI":"10.1186\/s12967-020-02522-6"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Malek, E., Kim, B.G. &amp; Driscoll, J.J.(2016)  Identification of Long Non-Coding RNAs Deregulated in Multiple Myeloma Cells Resistant to Proteasome Inhibitors.  <i>Genes<\/i> (<i>Basel<\/i>), 7, 84.","DOI":"10.3390\/genes7100084"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Mashouri, L., Yousefi, H., Aref, A.R., Ahadi, A.M., Molaei, F. &amp; Alahari, S.K.(2019)  Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance.  <i>Mol. Cancer<\/i>, 18, 75.","DOI":"10.1186\/s12943-019-0991-5"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Meng, Q., Liu, M. &amp; Cheng, R.(2020)  LINC00461\/miR-4478\/E2F1 feedback loop promotes non-small cell lung cancer cell proliferation and migration.  <i>Biosci. Rep<\/i>., 40, BSR20191345.","DOI":"10.1042\/BSR20191345"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Peng, Y., Wu, W., Shang, Z., Li, W. &amp; Chen, S.(2020)  Inhibition of lncRNA LINC00461\/miR-216a\/aquaporin 4 pathway suppresses cell proliferation, migration, invasion, and chemoresistance in glioma.  <i>Open Life Sci<\/i>., 15, 532-543.","DOI":"10.1515\/biol-2020-0048"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Qu, W., Huang, W., Yang, F., Ju, H. &amp; Zhu, G.(2020)  Long noncoding RNA LINC00461 mediates cisplatin resistance of rectal cancer via miR-593-5p\/CCND1 axis.  <i>Biomed. Pharmacother<\/i>., 124, 109740.","DOI":"10.1016\/j.biopha.2019.109740"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Riz, I., Hawley, T.S. &amp; Hawley, R.G.(2015)  KLF4-SQSTM1\/p62-associated prosurvival autophagy contributes to carfilzomib resistance in multiple myeloma models.  <i>Oncotarget<\/i>, 6, 14814-14831.","DOI":"10.18632\/oncotarget.4530"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Sun, S.W., Chen, Y., Liao, H.J., Zhang, W., Xu, W.M. &amp; He, G.Q.(2022)  LINC00461 Regulates the Recurrence of Large B Cell Lymphoma through the miR-411-5p\/BNIP3 Pathway.  <i>Evid. Based Complement. Alternat. Med<\/i>., 2022, 9100056.","DOI":"10.1155\/2022\/9100056"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Wang, Z., Hu, T., Jin, C., Yu, J., Zhu, D. &amp; Liu, J.(2020)  The anti-tumor effect of miR-539-3p on colon cancer via regulating cell viability, motility, and nude mouse tumorigenicity with CDK14 inhibition.  <i>J. Gastrointest. Oncol<\/i>., 11, 899-910.","DOI":"10.21037\/jgo-20-387"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Wu, Y., Zhang, Z., Wu, J., Hou, J. &amp; Ding, G.(2022)  The Exosomes Containing LINC00461 Originated from Multiple Myeloma Inhibit the Osteoblast Differentiation of Bone Mesenchymal Stem Cells via Sponging miR-324-3p.  <i>J. Healthc. Eng<\/i>., 2022, 3282860.","DOI":"10.1155\/2022\/3282860"},{"key":"26","unstructured":"Xu, W., Shi, Q., Qian, X., Zhou, B., Xu, J., Zhu, L., Feng, L., Jin, H. &amp; Wang, X.(2018)  Rab5a suppresses autophagy to promote drug resistance in cancer cells.  <i>Am. J. Transl. Res<\/i>., 10, 1229-1236."},{"key":"27","doi-asserted-by":"crossref","unstructured":"Yang, Y., Ren, M., Song, C., Li, D., Soomro, S.H., Xiong, Y., Zhang, H. &amp; Fu, H.(2017)  LINC00461, a long non-coding RNA, is important for the proliferation and migration of glioma cells.  <i>Oncotarget<\/i>, 8, 84123-84139.","DOI":"10.18632\/oncotarget.20340"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Yousaf, M. &amp; Ali, M.(2020)  Modulation of ABCG2 surface expression by Rab5 and Rab21 to overcome multidrug resistance in cancer cells.  <i>Xenobiotica<\/i>, 50, 988-996.","DOI":"10.1080\/00498254.2020.1716107"},{"key":"29","unstructured":"Yu, M.H., Luo, Y., Qin, S.L. &amp; Zhong, M.(2015)  Increased expression of Rab5A predicts metastasis and poor prognosis in colorectal cancer patients.  <i>Int. J. Clin. Exp. Pathol<\/i>., 8, 6974-6980."},{"key":"30","doi-asserted-by":"crossref","unstructured":"Zhang, C., Wang, J., Zhang, J., Qu, H. &amp; Tang, X.(2020)  LINC00461 Overexpression Can Induce Docetaxel Resistance in Breast Cancer by Interacting with miR-411-5p.  <i>Onco Targets Ther<\/i>., 13, 5551-5562.","DOI":"10.2147\/OTT.S247776"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Zhang, Q., Zhong, C., Shen, J., Chen, S., Jia, Y. &amp; Duan, S.(2022)  Emerging role of LINC00461 in cancer.  <i>Biomed. Pharmacother<\/i>., 152, 113239.","DOI":"10.1016\/j.biopha.2022.113239"},{"key":"32","unstructured":"Zhou, J., Su, M., Zhang, H., Wang, J. &amp; Chen, Y.(2019)  miR-539-3P inhibits proliferation and invasion of gastric cancer cells by targeting CTBP1.  <i>Int. J. Clin. Exp. Pathol<\/i>., 12, 1618-1625."},{"key":"33","doi-asserted-by":"crossref","unstructured":"Zhu, C., Zhou, R., Zhou, Q., Chang, Y. &amp; Jiang, M.(2016)  microRNA-539 suppresses tumor growth and tumorigenesis and overcomes arsenic trioxide resistance in hepatocellular carcinoma.  <i>Life Sci<\/i>., 166, 34-40.","DOI":"10.1016\/j.lfs.2016.10.002"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/265\/2\/265_2024.J082\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T04:23:02Z","timestamp":1742012582000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/265\/2\/265_2024.J082\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.2024.j082","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"type":"print","value":"0040-8727"},{"type":"electronic","value":"1349-3329"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"2024.J082"}}